Peter Mac scientists have developed a simple blood test that can show which men with the most aggressive type of prostate cancer should respond to conventional therapy, and those who need other options. From as little as 10ml of blood, ...
Read More »Post-doc position available – RNA-Seq
Generate transcriptomics data resulting from Prostate Cancer patients exosomes to detect biomarkers indicative of aggressive prostate cancer. This includes handling patient tissue, urine and...
Read More »Researchers use a combination of third generation long-read RNA sequencing technology and short-read RNAseq to characterize the splicing landscape of prostate cancer
Researchers from the Icahn School of Medicine characterize the transcriptional splicing landscape of a prostate cancer cell line treated with a previously identified synergistic drug combination. They use...
Read More »RNA-Seq Identifies a Panel of MicroRNAs as Diagnostic Biomarkers for Prostate Cancer
Prostate cancer is the most common non-cutaneous cancer among men; yet, current diagnostic methods are insufficient, and more reliable diagnostic markers need to be developed. One answer that can bridge this gap may lie in microRNAs. These small RNA molecules ...
Read More »Potential prostate cancer target identfied by RNA-Seq
Prostate cancer patients have been offered hope after scientists at Newcastle University have identified a new group of molecules that could be targeted to slow tumour growth. Experts used RNA sequencing to identify hundreds of genes were affected by the ...
Read More »Largest RNA-Seq study of its kind identifies three distinct molecular subtypes of prostate cancer
In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to ...
Read More »RNA-Seq Identifies New Treatment Target for Prostate Cancer Tumors
Prostate cancer patients have been offered hope after scientists at Newcastle University have identified a new group of molecules that could be targeted to slow tumour growth. A 3-year research project involved the use of an advanced screening technique called ...
Read More »RNA-Seq reveals new targets for prostate cancer screening, treatment
from UPI – by Stephen Feller – Glycan sugar groups are already a target for treatment in breast cancer and neuroblastoma. Researchers in England have identified a large group of genes that may be significant for better testing and treatment ...
Read More »RNA-Seq highlights racial disparities and vitamin D in prostate cancer
The results of clinical studies by investigators at the Medical University of South Carolina (MUSC) and the Ralph H. Johnson VA Medical Center (VAMC), reported in the July 2016 issue of Pharmacogenomics, demonstrate transcriptome-level linkages between racial disparities in circulating ...
Read More »Pseudotime Estimation – Deconfounding Single Cell Time Series
Repeated cross-sectional time series single cell data confound several sources of variation, with contributions from measurement noise, stochastic cell-to-cell variation and cell progression at different rates. Time series from single cell assays are particularly susceptible to confounding as the measurements ...
Read More »